Orchestra BioMed Holdings Inc. (OBIO) support and resistance · rev $2.6M
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
This page maps Orchestra BioMed Holdings Inc. (OBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OBIO revenue for 2024-12-31 was $2.6M. Net income was -$61.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. OBIO currently screens at market cap $231.7M.
OBIO currently screens at market cap $231.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OBIO quote page for the session range and the stock page for the full model.
Not investment advice.